US Stock MarketDetailed Quotes

INM InMed Pharmaceuticals

Watchlist

4.5000
-0.1600-3.43%

Close Nov 25 16:00 ET

3.23MMarket Cap-586P/E (TTM)

InMed Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Sep 30, 2024

(FY)Jun 30, 2024

(Q4)Jun 30, 2024

(Q3)Mar 31, 2024

(Q2)Dec 31, 2023

(Q1)Sep 30, 2023

(FY)Jun 30, 2023

(Q4)Jun 30, 2023

(Q3)Mar 31, 2023

(Q2)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

15.98%-1.83M

4.08%-6.99M

-56.42%-1.03M

-16.76%-1.93M

31.88%-1.85M

3.61%-2.17M

53.26%-7.28M

83.74%-657.93K

69.03%-1.66M

23.22%-2.71M

Net income from continuing operations

33.86%-1.68M

3.42%-7.68M

-472.61%-1.94M

13.77%-1.72M

29.65%-1.48M

27.73%-2.54M

57.27%-7.95M

95.70%-338.39K

42.52%-2M

50.94%-2.1M

Operating gains losses

161.15%5.27K

936.52%12.26K

1,110.99%9.66K

5,717.24%1.63K

-65.34%-1.04K

-27.83%2.02K

-90.99%1.18K

-165.50%-955

96.01%-29

-105.65%-629

Depreciation and amortization

-2.94%144.98K

1.43%604.52K

0.59%151.86K

1.02%150.69K

3.56%152.61K

0.58%149.36K

16.45%596K

-2.00%150.97K

-2.71%149.16K

-1.74%147.36K

Other non cash items

3.53%-519

-55.67%-1.25K

105.11%21

-1,069.23%-252

-61.41%-481

-348.33%-538

-100.06%-803

-100.03%-411

--26

---298

Change In working capital

-449.85%-327.64K

34.73%-369.34K

352.62%665.61K

-395.36%-418.82K

16.90%-709.77K

-77.16%93.65K

81.59%-565.82K

80.85%-263.48K

106.39%141.8K

-340.14%-854.16K

-Change in receivables

-27.93%68.14K

57.82%-92.44K

-29.85%-145.16K

286.33%165.19K

-126.09%-207.02K

29.77%94.55K

-447.76%-219.15K

-539.79%-111.79K

-337.79%-88.65K

-14,451.57%-91.56K

-Change in inventory

-93.79%24.25K

-88.29%66.22K

-399.09%-92.78K

-258.38%-449.11K

31.98%217.78K

187.94%390.33K

128.23%565.56K

98.26%-18.59K

165.71%283.58K

132.89%165.02K

-Change in prepaid assets

16.20%328.87K

-93.22%20.28K

174.35%540.94K

-28.42%94.29K

-90.95%-897.96K

-35.76%283.02K

56.92%299.19K

-61.66%197.17K

111.25%131.73K

-320.82%-470.27K

-Change in payables and accrued expense

-14.21%-642.39K

105.61%45.28K

312.82%470.73K

-36.45%-104.34K

169.04%241.38K

-253.19%-562.48K

0.62%-806.53K

64.12%-221.19K

84.44%-76.47K

-145.66%-349.61K

-Change in other current assets

--0

-10.88%4.91K

--0

--1.79K

-43.38%3.12K

108.96%5.51K

--0

-Change in other current liabilities

-7.90%-106.51K

6.83%-397.42K

0.88%-108.12K

11.24%-96.19K

12.76%-94.4K

2.17%-98.71K

-24.78%-426.58K

0.13%-109.09K

-0.81%-108.38K

---108.21K

-Change in other working capital

----

-200.00%-16.17K

--0

---28.66K

5,984.08%28.66K

-203.00%-16.17K

414.49%16.17K

--0

--471

Cash from discontinued investing activities

Operating cash flow

15.98%-1.83M

4.08%-6.99M

-56.42%-1.03M

-16.76%-1.93M

31.88%-1.85M

3.61%-2.17M

53.26%-7.28M

83.74%-657.93K

69.03%-1.66M

23.22%-2.71M

Investing cash flow

Cash flow from continuing investing activities

98.60%-9.29K

100.00%-2

98.14%-9.29K

1.66%-661.8K

95.37%-33.61K

-3,508.16%-128.2K

-263.39%-500K

Net PPE purchase and sale

----

94.26%-9.29K

--0

100.00%-2

----

-313.74%-161.8K

---33.61K

-3,508.16%-128.2K

----

Net business purchase and sale

----

--0

----

-139.36%-500K

--0

----

Net investment purchase and sale

--0

Cash from discontinued investing activities

Investing cash flow

--0

98.60%-9.29K

--0

100.00%-2

98.14%-9.29K

--0

1.66%-661.8K

95.37%-33.61K

-3,508.16%-128.2K

-263.39%-500K

Financing cash flow

Cash flow from continuing financing activities

838.24K

-56.42%4.65M

176

-12.44%4.65M

-29.13%10.68M

-117.31%-63.7K

735.69%5.32M

Net common stock issuance

--1.03M

-56.42%4.65M

100.15%1

--0

-1.90%4.65M

--0

-37.71%10.68M

-100.01%-646

---63.7K

2,695,346.59%4.74M

Proceeds from stock option exercised by employees

----

-72.91%175

----

--646

----

Net other financing activities

---191.82K

----

Cash from discontinued financing activities

Financing cash flow

--838.24K

-56.42%4.65M

--176

--0

-12.44%4.65M

--0

-29.13%10.68M

--0

-117.31%-63.7K

735.69%5.32M

Net cash flow

Beginning cash position

-26.27%6.57M

44.29%8.91M

-20.86%7.6M

-16.74%9.53M

-27.94%6.74M

44.29%8.91M

-16.11%6.18M

62.83%9.6M

1.53%11.45M

-39.06%9.35M

Current changes in cash

54.53%-988.57K

-185.57%-2.34M

-48.80%-1.03M

-4.64%-1.93M

33.04%2.8M

-168.51%-2.17M

330.61%2.74M

-348.26%-691.54K

65.65%-1.85M

151.73%2.1M

End cash Position

-17.14%5.58M

-26.27%6.57M

-20.86%7.6M

-16.74%9.53M

-27.94%6.74M

44.29%8.91M

62.83%9.6M

1.53%11.45M

Free cash flow

15.98%-1.83M

6.04%-7M

-48.82%-1.03M

-8.38%-1.93M

31.54%-1.86M

3.61%-2.17M

52.35%-7.45M

82.91%-691.54K

66.65%-1.78M

23.99%-2.71M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Sep 30, 2024	(FY)Jun 30, 2024	(Q4)Jun 30, 2024	(Q3)Mar 31, 2024	(Q2)Dec 31, 2023	(Q1)Sep 30, 2023	(FY)Jun 30, 2023	(Q4)Jun 30, 2023	(Q3)Mar 31, 2023	(Q2)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	15.98%-1.83M	4.08%-6.99M	-56.42%-1.03M	-16.76%-1.93M	31.88%-1.85M	3.61%-2.17M	53.26%-7.28M	83.74%-657.93K	69.03%-1.66M	23.22%-2.71M
Net income from continuing operations	33.86%-1.68M	3.42%-7.68M	-472.61%-1.94M	13.77%-1.72M	29.65%-1.48M	27.73%-2.54M	57.27%-7.95M	95.70%-338.39K	42.52%-2M	50.94%-2.1M
Operating gains losses	161.15%5.27K	936.52%12.26K	1,110.99%9.66K	5,717.24%1.63K	-65.34%-1.04K	-27.83%2.02K	-90.99%1.18K	-165.50%-955	96.01%-29	-105.65%-629
Depreciation and amortization	-2.94%144.98K	1.43%604.52K	0.59%151.86K	1.02%150.69K	3.56%152.61K	0.58%149.36K	16.45%596K	-2.00%150.97K	-2.71%149.16K	-1.74%147.36K
Other non cash items	3.53%-519	-55.67%-1.25K	105.11%21	-1,069.23%-252	-61.41%-481	-348.33%-538	-100.06%-803	-100.03%-411	--26	---298
Change In working capital	-449.85%-327.64K	34.73%-369.34K	352.62%665.61K	-395.36%-418.82K	16.90%-709.77K	-77.16%93.65K	81.59%-565.82K	80.85%-263.48K	106.39%141.8K	-340.14%-854.16K
-Change in receivables	-27.93%68.14K	57.82%-92.44K	-29.85%-145.16K	286.33%165.19K	-126.09%-207.02K	29.77%94.55K	-447.76%-219.15K	-539.79%-111.79K	-337.79%-88.65K	-14,451.57%-91.56K
-Change in inventory	-93.79%24.25K	-88.29%66.22K	-399.09%-92.78K	-258.38%-449.11K	31.98%217.78K	187.94%390.33K	128.23%565.56K	98.26%-18.59K	165.71%283.58K	132.89%165.02K
-Change in prepaid assets	16.20%328.87K	-93.22%20.28K	174.35%540.94K	-28.42%94.29K	-90.95%-897.96K	-35.76%283.02K	56.92%299.19K	-61.66%197.17K	111.25%131.73K	-320.82%-470.27K
-Change in payables and accrued expense	-14.21%-642.39K	105.61%45.28K	312.82%470.73K	-36.45%-104.34K	169.04%241.38K	-253.19%-562.48K	0.62%-806.53K	64.12%-221.19K	84.44%-76.47K	-145.66%-349.61K
-Change in other current assets	--0	-10.88%4.91K	--0	--0	--1.79K	-43.38%3.12K	108.96%5.51K	--0	--0	--0
-Change in other current liabilities	-7.90%-106.51K	6.83%-397.42K	0.88%-108.12K	11.24%-96.19K	12.76%-94.4K	2.17%-98.71K	-24.78%-426.58K	0.13%-109.09K	-0.81%-108.38K	---108.21K
-Change in other working capital	----	-200.00%-16.17K	--0	---28.66K	5,984.08%28.66K	-203.00%-16.17K	414.49%16.17K	--0	--0	--471
Cash from discontinued investing activities
Operating cash flow	15.98%-1.83M	4.08%-6.99M	-56.42%-1.03M	-16.76%-1.93M	31.88%-1.85M	3.61%-2.17M	53.26%-7.28M	83.74%-657.93K	69.03%-1.66M	23.22%-2.71M
Investing cash flow
Cash flow from continuing investing activities	0	98.60%-9.29K	0	100.00%-2	98.14%-9.29K	0	1.66%-661.8K	95.37%-33.61K	-3,508.16%-128.2K	-263.39%-500K
Net PPE purchase and sale	----	94.26%-9.29K	--0	100.00%-2	----	----	-313.74%-161.8K	---33.61K	-3,508.16%-128.2K	----
Net business purchase and sale	----	--0	--0	--0	----	----	-139.36%-500K	--0	--0	----
Net investment purchase and sale	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cash from discontinued investing activities
Investing cash flow	--0	98.60%-9.29K	--0	100.00%-2	98.14%-9.29K	--0	1.66%-661.8K	95.37%-33.61K	-3,508.16%-128.2K	-263.39%-500K
Financing cash flow
Cash flow from continuing financing activities	838.24K	-56.42%4.65M	176	0	-12.44%4.65M	0	-29.13%10.68M	0	-117.31%-63.7K	735.69%5.32M
Net common stock issuance	--1.03M	-56.42%4.65M	100.15%1	--0	-1.90%4.65M	--0	-37.71%10.68M	-100.01%-646	---63.7K	2,695,346.59%4.74M
Proceeds from stock option exercised by employees	----	-72.91%175	----	----	----	----	--646	----	----	----
Net other financing activities	---191.82K	----	----	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	--838.24K	-56.42%4.65M	--176	--0	-12.44%4.65M	--0	-29.13%10.68M	--0	-117.31%-63.7K	735.69%5.32M
Net cash flow
Beginning cash position	-26.27%6.57M	44.29%8.91M	-20.86%7.6M	-16.74%9.53M	-27.94%6.74M	44.29%8.91M	-16.11%6.18M	62.83%9.6M	1.53%11.45M	-39.06%9.35M
Current changes in cash	54.53%-988.57K	-185.57%-2.34M	-48.80%-1.03M	-4.64%-1.93M	33.04%2.8M	-168.51%-2.17M	330.61%2.74M	-348.26%-691.54K	65.65%-1.85M	151.73%2.1M
End cash Position	-17.14%5.58M	-26.27%6.57M	-26.27%6.57M	-20.86%7.6M	-16.74%9.53M	-27.94%6.74M	44.29%8.91M	44.29%8.91M	62.83%9.6M	1.53%11.45M
Free cash flow	15.98%-1.83M	6.04%-7M	-48.82%-1.03M	-8.38%-1.93M	31.54%-1.86M	3.61%-2.17M	52.35%-7.45M	82.91%-691.54K	66.65%-1.78M	23.99%-2.71M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data